Page 12 - Ayurvedic Sciences News Today

Antiviral drug Clevira repurposed for treating mild to moderate COVID-19 patients The drug is effective when taken orally and the dosage is one tablet twice daily after food for 14 days. Share Via Email   |  A+A A- Beds lie inside an indoor stadium converted into COVID-19 treatment center for emergencies in the wake of the spike in the numbers of positive coronavirus cases in Srinagar. (Photo | AP) By PTI NEW DELHI: Clevira, a drug primarily developed to treat dengue, has been repurpose...

Share Bhubaneswar: Apex Laboratories Private Limited, a Chennai based pharmaceutical company known for its cutting-edge research and innovation, introduces Clevira, an antiviral herbal formulation. Clevira was developed primarily to treat dengue patients in 2017. Last year as the COVID-19 cases surged in the country, it was repurposed as supportive treatment for mild to moderate COVID symptoms. The product is available across India and is priced at Rs 11 per tablet. A clinical trial was conduct...

Poly herbal drug Ayush 64 is useful in mild to moderate Covid cases April 30, 2021 Originally developed for treating malaria in 1980, it is now repurposed to treat Covid-19 Ayush 64, a poly herbal formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), could be effective in treating asymptomatic, mild and moderate Covid-19 infection if it is used as an adjunct to standard care, a statement from Ayush Ministry said on Thursday. The herbal drug, developed for ...

Ayush Ministry has said that scientists have found that ayurvedic medicine AYUSH 64 is also proving useful in the treatment of asymptomatic, mild and moderate COVID-19 infection as an adjunct to standard care.

Poly Herbal Formulation AYUSH-64 Found Useful In Treatment Of Mild To Moderate COVID-19 Infection: AYUSH Ministry by Swarajya Staff - Apr 29, 2021 11:52 AM AYUSH-64 (Pic Via Twitter) The scientists of reputed research institutions of the country have found that AYUSH 64, a poly herbal formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) under the Ministry of Ayush, is useful in the treatment of asymptomatic, mild and moderate COVID-19 infection as an adjunct t...

Fresh COVID-19 guidelines released for Ayurveda, Unani practitioners Guidelines aimed to increase awareness among citizens regarding effective home care solutions and recommended Ayush practices By ANI|   Posted by Sameer  |   Published: 27th April 2021 8:36 am IST ministry of ayush logo New Delhi: Responding to the need for fresh guidelines amid the second wave of COVID-19 pandemic, the Ministry of Ayush has released revised guidelines for Ayurveda and Unani practitioners for COVID-19 pa...

City based pharma company Apex Laboratories will take the doctors prescription route for its oral antiviral CleVira tablet that got the Central governments approval as a supporting measure for mild to moderate condition of Covid-19, a senior ...

Apex Laboratories Gets Approval For Oral Antiviral CleVira As COVID Supportive Drug by Colleen Fleiss on  April 24, 2021 at 5:33 PM Apex Laboratories has received approval from the Central Government for its oral antiviral CleVira drug as a supporting measure for mild to moderate condition of COVID-19, a senior official said. The company said this is the first of its kind approval in India through various stages of scrutiny at The Central Council for Research in Ayurvedic Sc...

Orissa High Court on Friday (09 th April) dismissed a plea which claimed that that Kaai (Kukuti) Chutney (paste) which is prepared using red ants, can prevent infection through the COVID-19 virus. Dismissing the plea, the bench of Chief Justice S. Muralidhar and Justice B. P. Routray said that the use of red ant chutney or soup by the tribal communities for medicinal and therapeutic purposes is based on their traditional knowledge systems which the Court is hardly equipped to comment ...